Intraday Analysis – Gold Getting Back on Track – Orbex Forex Trading Blog

The Australian dollar continues to have a quiet week. AUD/USD is trading at 0.6671 in the European session, up 0.17% today at the time of writing. With the Australian economy sputtering, it should come as no surprise that today’s confidence indicators pointed downward. Westpac consumer confidence change declined 0.5% m/m in September, falling from 85.0…

Most retail traders do not fail because they cannot read a chart. They fail because they approach the market like gamblers, not professionals. If you want to learn how to trade forex professionally, you need to stop looking for excitement and start building structure. That means rules, records, risk control, and the patience to repeat…

The Time Zone and Nonlagdot Non Repaint Forex Trading Strategy offers traders a unique approach to navigating the ever-changing forex market. Combining time-based trading insights with the precision of the Nonlagdot indicator, this strategy focuses on maximizing entry and exit accuracy. Time zones play a pivotal role in forex trading as they influence market activity…

GBPUSD: The British pound remains under pressure amid increased risk-off sentiment linked to new White House statements about additional tariffs from August 1. This is boosting demand for the US dollar as a safe haven and prompts investors to take profits on long GBP positions. Domestic factors in the…

Want to start forex trading but don’t know where to begin? Here’s a quick guide to help you get started safely and confidently: Understand Forex Basics: Learn key terms like base currency, quote currency, pip, and leverage. Example: In EUR/USD, EUR is the base, USD is the quote, and a pip is the smallest price…

CAMBRIDGE, Massachusetts, March 11, 2025 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced that Neil Warma, Chief Executive Officer…